CrushSCI.com
125.4Average days
98Median days
60Fastest days
538Longest days
4082025 publications

Paper Review Records

All Paper Review Records

15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

84 days

FABP4 characterizes metabolic–immune interactions and serves as a prognostic biomarker across gynecologic malignancies: a multi-omics integrative analysis

Authors
Fangfang Chen; Lifeng Dong; Saisa Zhu; Zhiyuan Bo; Yangfan Fan; Yizhou Huang; Yiding Chen; Fang WanShow moreShow less
Affiliations
Department of Breast Surgery, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China; Department of Gynecology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China; Department of Breast Surgery, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, ChinaShow moreShow less
Source PDF DOI Publisher page
95 days

A multi-stage prospective study evaluates serum metabolomic signatures for the differential diagnosis and prognostic stratification of PDAC

Authors
Zhouyu Ning; Ying Zhu; Hui Li; Zhiqiang MengShow moreShow less
Affiliations
Department of Minimally invasive therapy center, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China; Department of Integrative Oncology, Fudan University Shanghai Cancer Centre, Shanghai, ChinaShow moreShow less
Source PDF DOI Publisher page
75 days

In vivo and FACS-based CRISPR/Cas9 screening uncovers VENTX as a crucial element in maintaining seminoma stemness

Authors
Chaoxiong Huang; Yiran Chen; Enhuan Zhang; Yifan Wang; Yixuan Liu; Lirui Tang; Chuanben Chen; Peicheng Lin; Bingyi WangShow moreShow less
Affiliations
Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China; Anxi County Hospital, Quanzhou, 362400, ChinaShow moreShow less
Source PDF DOI Publisher page
101 days

Dinutuximab beta with TEMIRI chemotherapy in relapsed/refractory neuroblastoma: Real-world insights into the open question of GD2 expression

Authors
Maria Antonietta De Ioris; Francesca Del Bufalo; Concetta Quintarelli; Valentina Bertaina; Francesco Fabozzi; Maria Giuseppina Cefalo; Iside Alessi; Chiara Grimaldi; Maria Felicia Villani; Maria Luisa D’Andrea; Alessandra Stracuzzi; Claudio Altini; Carmen Malaspina; Matilde Sinibaldi; Stefano Di Cecca; Laura Iaffaldano; Clelia Geraci; Marco Becilli; Biagio De Angelis; Alessandro Crocoli; Giulia Cassanelli; Stefano Margaritora; Angela Mastronuzzi; Franco LocatelliShow moreShow less
Affiliations
Pediatric Hematology and Oncology, Cell and Gene Therapy, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy; Surgical Oncology Unit, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy; Nuclear Medicine Unit, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy; Radiology Unit, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy; Pathology Unit, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy; Thoracic Surgery, Catholic University of the Sacred Heart, Rome, Italy; Department of Life Sciences and Public Health, Catholic University of the Sacred Heart, Rome, ItalyShow moreShow less
Source PDF DOI Publisher page
106 days

A multi-temporal MRI radiomics model for early post-ablation recurrence risk stratification in hepatocellular carcinoma

Authors
Yihang Xu; Liting Peng; Junbin Liao; Zixin Huang; Shiyi Liu; Shuo Wang; Yuxi Huang; Xiaofei Qu; Manxia Lin; Jingxian Shen; Ruiming LiangShow moreShow less
Affiliations
Division of Gastrointestinal Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China; Center of Hepato-Pancreato-Biliary Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China; Division of Interventional Ultrasound, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China; Department of Gastroenterology and Hepatology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China; Department of Imaging Diagnosis and Interventional Center, Sun Yat-sen University Cancer Center, Guangzhou, China; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangdong Provincial Clinical Research Center for Cancer, Guangdong Esophageal Cancer Institute, Guangzhou, China; Department of Medical Statistics, Clinical Trials Unit, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, ChinaShow moreShow less
Source PDF DOI Publisher page
73 days

A chemoresistance-associated proliferation gene signature identified by single-cell and machine learning analysis predicts prognosis in high-grade serous ovarian carcinoma

Authors
Yanmin Zhang; Sihuang Wu; Huizhu Lin; Ling LiShow moreShow less
Affiliations
Department of Gynecology and Obstetrics, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou 450014, China; Henan Gynecological Diseases (Gynecology Oncology) Clinical Research Center, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou 450014, China; Cell-Gene Therapy Translational Medicine Research Centre, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510630, China; Biotherapy Center, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510630, China; Department of Gynecology and Obstetrics, High-Risk Perinatal Medicine Center, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, ChinaShow moreShow less
Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review62 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at [email protected]

Enter your email address so we can reply. Your details will remain private.